Access personalized Cystolitholapaxy care using advanced medical technology, supported by expert specialists and dedicated international patient services.
Choosing ID Hospital for Cystolitholapaxy gives patients access to experienced endourologists, advanced cystoscopic equipment, laser stone-fragmentation technology, urinary imaging, specialized anesthesia services, and structured postoperative monitoring. Established in 2017, the JCI, NABH accredited hospital in Seoul, South Korea has 25 beds and provides specialized treatment for urinary stones.
Cystolitholapaxy is generally performed under appropriate anaesthesia through the natural urinary passage. The urologist introduces a cystoscope into the bladder, identifies the stone, fragments it using suitable energy or mechanical instruments, and removes the resulting pieces. A urinary catheter may be placed temporarily after the procedure depending on the extent of treatment. Patients may experience temporary burning during urination, urinary frequency, blood in the urine, or discomfort, while potential complications include infection, bleeding, bladder injury, or incomplete stone clearance.